Gong, Tingting
Jaratlerdsiri, Weerachai
Jiang, Jue
Willet, Cali
Chew, Tracy
Patrick, Sean M.
Lyons, Ruth J.
Haynes, Anne-Maree
Pasqualim, Gabriela
Brum, Ilma Simoni
Stricker, Phillip D.
Mutambirwa, Shingai B. A.
Sadsad, Rosemarie
Papenfuss, Anthony T.
Bornman, Riana M. S.
Chan, Eva K. F.
Hayes, Vanessa M. http://orcid.org/0000-0002-4524-7280
Funding for this research was provided by:
National Health and Medical Research Council (APP1165762, APP2010551)
University of Sydney (G199756)
Petre Foundation (Chair Prostate Cancer Research)
DOD Prostate Cancer Research Program (PC200390)
Article History
Received: 12 April 2022
Accepted: 28 July 2022
First Online: 31 August 2022
Declarations
:
: Irrespective of country of origin, all individuals provided informed consent to participate in the study. Conforming to the principles of the Helsinki Declaration, South African patients were recruited as part of the Southern African Prostate Cancer Study (SAPCS) with approval granted by the University of Pretoria Faculty of Health Sciences Research Ethics Committee (HREC, with US Federal wide assurance FWA00002567 and IRB00002235 IORG0001762; #43/2010). In Australia, participant recruitment was approved by the St Vincent’s HREC (#SVH/12/231) and in Brazil by the Grupo de Pesquisa e Pós-Graduação (GPPG) Scientific Committee and Research Ethical Commission (#20160539). Samples were shipped to the Garvan Institute of Medical Research in accordance with institutional Material Transfer Agreements (MTAs), as well as additional Republic of South Africa Department of Health Export Permit (National Health Act 2003; J1/2/4/2 #1/12). This study was approved by the St. Vincent’s HREC (#SVH/15/227) for genomic interrogation.
: Not applicable.
: The authors declare that they have no competing interests.